user

ONE YEAR FOLLOW-UP OF PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE U300 IN CLINICAL PRACTICE

被引：0
|
作者：
Bramlage, P. [1 ]
Lanzinger, S. [2 ]
Danne, T. [3 ]
Muehldorfer, S. [4 ]
Hess, G. M.
Naudorf, M. [5 ]
Holl, R. [2 ]
机构：
[1] Inst Pharmacol & Prevent Med, Mahlow, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry ZIBMT, Ulm, Germany
[3] Childrens Hosp, BULT Diabetol Endocrinol Gastroenterol & Clin Res, Hannover, Germany
[4] Klinikum Bayreuth GmbH, Gastroenterol Clin, Bayreuth, Germany
[5] Diabet Ctr Lindlar, Med Practice, Lindlar, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
095
引用
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [1] Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice
    Carral San Laureano, Florentino
    Tome Fernandez-Ladreda, Mariana
    Jimenez Millan, Ana Isabel
    Garcia Calzado, Concepcion
    Ayala Ortega, Maria del Carmen
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (05) : 983 - 988
  • [2] Dosage profile of insulin glargine U100 and U300 in patients with type 2 diabetes in real clinical practice: DosInGlar study
    Duque, N.
    Artime, E.
    Romera, I.
    Lebrec, J.
    Diaz, S.
    Sicras, A.
    Reviriego, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S320 - S320
  • [3] Pharmacodynamic and pharmacokinetic evaluation of insulin glargine U300 for the treatment of type 1 diabetes
    Hurren, Kathryn M.
    O'Neill, Jessica L.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (12) : 1521 - 1526
  • [4] Effect of Telephone Coaching Support on Glycemic Control in Type 2 Diabetes Treated with Glargine U300 Insulin
    Bellido Guerrero, Diego, Sr.
    Bellido, Virginia
    Morales, Cristobal, Sr.
    Garcia, Jose, Sr.
    Munoz-Garach, Araceli
    Fernandez Morera, Juan Luis
    Gonzalez Aguilera, Beatriz
    Lopez De la Torre, Martin
    Fuentealba, Paulina
    DIABETES, 2019, 68
  • [5] Insulin Glargine U300 experiences in children diagnosed with type 1 diabetes: early results
    Erbas, I. M.
    Basa, E. G.
    Koprulu, O.
    Nalbantoglu, O.
    Korkmaz, H. A.
    Ozkan, B.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 305 - 306
  • [6] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    DIABETOLOGIA, 2018, 61 : S44 - S44
  • [7] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Urrutia, M. Agustina
    Cardona, Saumeth
    Albury, Bonnie
    Galindo, Rodolfo J.
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES CARE, 2020, 43 (06) : 1242 - 1248
  • [8] Experience after switching from insulin glargine U100 to glargine U300 in patients with type 1 diabetes mellitus. A study after one year of treatment in real life
    Pujante Alarcon, Pedro
    Rodriguez Escobedo, Raul
    Garcia Urruzola, Fernando
    Ares, Jessica
    Manjon, Laura
    Sanchez Ragnarson, Cecilia
    Cacho, Laura
    Delgado, Elias
    Menendez Torre, Edelmiro L.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (04): : 210 - 216
  • [9] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Cardona, Saumeth
    Shakally, Almoutaz
    Lyerla, Ryan C.
    Anzola, Isabel
    Albury, Bonnie S.
    Haw, J. Sonya
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES, 2019, 68
  • [10] Reduced risk of hypoglycaemia and lower HbA1c with degludec compared to glargine U300 in insulin-treated patients with type 2 diabetes
    Philis-Tsimikas, A.
    Klonoff, D. C.
    Khunti, K.
    Bajaj, H. S.
    Leiter, L. A.
    Tutkunkardas, D.
    Troelsen, L. Norgard
    Bak, B. A.
    Heller, S. R.
    Pieber, T. R.
    DIABETOLOGIA, 2019, 62 : S47 - S47
12345